Literature DB >> 31444602

ASO Author Reflections: Does Genomic Testing of DCIS Provide Added Value? And Is It Worth the Cost?

Kimberly J Van Zee1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31444602      PMCID： PMC6906222          DOI： 10.1245/s10434-019-07745-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  5 in total

1.  Comparison of Local Recurrence Risk Estimates After Breast-Conserving Surgery for DCIS: DCIS Nomogram Versus Refined Oncotype DX Breast DCIS Score.

Authors:  Kimberly J Van Zee; Emily C Zabor; Rosemarie Di Donato; Bryan Harmon; Jana Fox; Monica Morrow; Hiram S Cody; Susan A Fineberg
Journal:  Ann Surg Oncol       Date:  2019-07-24       Impact factor: 5.344

2.  Impact of Age on Risk of Recurrence of Ductal Carcinoma In Situ: Outcomes of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years.

Authors:  Patricia A Cronin; Cristina Olcese; Sujata Patil; Monica Morrow; Kimberly J Van Zee
Journal:  Ann Surg Oncol       Date:  2016-05-19       Impact factor: 5.344

3.  Relationship Between Margin Width and Recurrence of Ductal Carcinoma In Situ: Analysis of 2996 Women Treated With Breast-conserving Surgery for 30 Years.

Authors:  Kimberly J Van Zee; Preeti Subhedar; Cristina Olcese; Sujata Patil; Monica Morrow
Journal:  Ann Surg       Date:  2015-10       Impact factor: 12.969

4.  Decreasing Recurrence Rates for Ductal Carcinoma In Situ: Analysis of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years.

Authors:  Preeti Subhedar; Cristina Olcese; Sujata Patil; Monica Morrow; Kimberly J Van Zee
Journal:  Ann Surg Oncol       Date:  2015-07-28       Impact factor: 5.344

Review 5.  Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.

Authors:  C Correa; P McGale; C Taylor; Y Wang; M Clarke; C Davies; R Peto; N Bijker; L Solin; S Darby
Journal:  J Natl Cancer Inst Monogr       Date:  2010
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.